[go: up one dir, main page]

DK0971930T3 - Fremgangsmåde til fremstilling af enkelt enantiomert narwedin - Google Patents

Fremgangsmåde til fremstilling af enkelt enantiomert narwedin

Info

Publication number
DK0971930T3
DK0971930T3 DK98915005T DK98915005T DK0971930T3 DK 0971930 T3 DK0971930 T3 DK 0971930T3 DK 98915005 T DK98915005 T DK 98915005T DK 98915005 T DK98915005 T DK 98915005T DK 0971930 T3 DK0971930 T3 DK 0971930T3
Authority
DK
Denmark
Prior art keywords
narwedine
preparation
single enantiomeric
solvent
single enantiomer
Prior art date
Application number
DK98915005T
Other languages
Danish (da)
English (en)
Inventor
Gerard Andrew De Montfo Potter
Peter David Chirotech T Tiffen
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK0971930T3 publication Critical patent/DK0971930T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
DK98915005T 1997-04-11 1998-04-08 Fremgangsmåde til fremstilling af enkelt enantiomert narwedin DK0971930T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9707413.2A GB9707413D0 (en) 1997-04-11 1997-04-11 Process
PCT/GB1998/001029 WO1998046610A1 (fr) 1997-04-11 1998-04-08 Procede de preparation de narwedine possedant un seul enantiomere

Publications (1)

Publication Number Publication Date
DK0971930T3 true DK0971930T3 (da) 2004-01-26

Family

ID=10810680

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98915005T DK0971930T3 (da) 1997-04-11 1998-04-08 Fremgangsmåde til fremstilling af enkelt enantiomert narwedin

Country Status (15)

Country Link
US (1) US6392038B1 (fr)
EP (1) EP0971930B1 (fr)
JP (1) JP4322317B2 (fr)
KR (1) KR100523125B1 (fr)
AT (1) ATE253579T1 (fr)
AU (1) AU726812B2 (fr)
CA (1) CA2284976C (fr)
DE (1) DE69819479T2 (fr)
DK (1) DK0971930T3 (fr)
ES (1) ES2209125T3 (fr)
GB (1) GB9707413D0 (fr)
NO (1) NO325949B1 (fr)
NZ (1) NZ337962A (fr)
PT (1) PT971930E (fr)
WO (1) WO1998046610A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1875004B (zh) * 2003-09-26 2010-06-23 台湾神隆股份有限公司 那维啶酰胺衍生物的拆分
WO2005065662A1 (fr) * 2003-12-31 2005-07-21 Actavis Group Hf Formulations solides d'administration de galantamine
US20050191349A1 (en) * 2003-12-31 2005-09-01 Garth Boehm Galantamine formulations
WO2006046096A2 (fr) * 2004-08-16 2006-05-04 Ranbaxy Laboratories Limited Forme polymorphe de la narwedine et son utilisation dans la synthese de la galantamine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5428159A (en) * 1994-04-08 1995-06-27 Ciba-Geigy Corporation Method of manufacture of (-)-galanthamine in high yield and purity substantially free of epigalanthamine
SI0787115T1 (en) * 1994-10-21 2000-04-30 Sanochemia Pharmazeutika Ag PROCESS FOR PRODUCING DERIVATIVES OF 4a,5,9,10,11,12,-HEXAHYDRO-6H-BENZOFURO(3a,3,2-ef)(2)BENZAZEPINE

Also Published As

Publication number Publication date
KR20010006117A (ko) 2001-01-26
PT971930E (pt) 2004-02-27
US6392038B1 (en) 2002-05-21
EP0971930B1 (fr) 2003-11-05
ES2209125T3 (es) 2004-06-16
JP2001518911A (ja) 2001-10-16
CA2284976A1 (fr) 1998-10-22
KR100523125B1 (ko) 2005-10-19
AU6929698A (en) 1998-11-11
NO994928D0 (no) 1999-10-08
ATE253579T1 (de) 2003-11-15
DE69819479T2 (de) 2004-08-26
GB9707413D0 (en) 1997-05-28
CA2284976C (fr) 2006-10-17
JP4322317B2 (ja) 2009-08-26
WO1998046610A1 (fr) 1998-10-22
NZ337962A (en) 2001-05-25
DE69819479D1 (de) 2003-12-11
NO325949B1 (no) 2008-08-25
EP0971930A1 (fr) 2000-01-19
AU726812B2 (en) 2000-11-23
NO994928L (no) 1999-10-08

Similar Documents

Publication Publication Date Title
ATE240139T1 (de) Co-kristallisationsprozess
DK1042314T3 (da) Fremgangsmåde til fremstilling af enantiomert berigede tetrahydrobenzothiepinoxider
DK0960109T3 (da) Fremgangsmåde til fremstilling af tolterodin
PT756594E (pt) Preparacao de oxadiazinas artropodicidas
YU92303A (sh) Optička rezolucija (1-benzil-4-metilpiperidin-3-il)- metilamina i njegova primena za dobijanje pirolo 2,3-pirimidin derivata protein kinaze
BR0002073A (pt) Processo para a preparação de um composto quiral
DK0958281T3 (da) Opspaltning af ritalinsyresalt
DK0971930T3 (da) Fremgangsmåde til fremstilling af enkelt enantiomert narwedin
DK0407212T3 (da) Enantioselektiv syntese af antifolater
ATE183995T1 (de) Herstellung von mit enantiomer angereicherten ortho-substituierten alpha, alpha-diaromatischen methanolen
BR0015805B1 (pt) processo para preparar compostos opticamente ativos, e, composto opticamente ativo.
IT1293777B1 (it) Processo per la preparazione di tetraazamacrocicli
BR9810685B1 (pt) processo para a prepraração de um composto.
DK0880525T3 (da) Fremgangsmåde til fremstilling af galanthamin
TW341559B (en) Process for racemization of optically active 1-phenylethylamine derivative
DK1140794T3 (da) Hidtil ukendt fremgangsmåde til fremstilling af chirale aminosyrer
DK1017666T3 (da) Fremgangsmåde til at forøge den optiske renhed af 2R-[1-hydroxy-1-trifluormethyl-3-cyclopropylpropyn-2-yl]-4-chloranilin
BR9909627A (pt) Processo para a produção de r-(+)-6-carboxiamido-3-n-metila-mino-1,2,3,4-tetrahidr ocarbazol
DK0968997T3 (da) Fremgangsmåde til fremstilling af S-aryl-L-cystein og derivater
PT89029A (pt) Processo para a preparacao de novos derivados substituidos de 20,21-dinoreburnamenina
MY117689A (en) A new process for the preparation of 3-n, n-dicycobutylamino-8-fluoro-3, 4-dihydro-2h-1-benzopyran-5-carboxamide
DK0971907T3 (da) Fremgangsmåde til fremstilling af 1,3-disubstituerede 2-nitroguanidiner
DK0778827T3 (da) Fremgangsmåde til fremstilling af en beta-aminoalkohol
GEP19991791B (en) Pharmacologically Active Enantiomers and Process for its Production
SE9801726D0 (sv) New process